As the Director of Translational Informatics at Eli Lilly, Dr. Yue Webster leads a multidisciplinary team to deliver innovative solutions for Lilly’s Research and Development division. She has 20 years’ experience in quantitative disciplines: Cancer Genomics, Toxicology, Computational Chemistry, and Artificial Intelligence. Yue has developed computational applications for Oncology, Diabetes, Neuroscience, and Immunology. She has published in Cancer Cell, Nature Pharmacogenomic, Journal of Medicinal Chemistry, and other research journals. As the Business Relationship Manager between Oncology Research and RIDS (Research Information & Digital Solutions), Dr. Webster works closely with scientific partners to jointly define and deliver value from public and proprietary datasets including -omics, pre-clinical, clinical and real-world data.